Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

TSMC, Samsung Lead Recovery In Asia's Emerging Markets With AI And Chip Sector Growth

Published 05/03/2024, 13:32
Updated 05/03/2024, 14:40
© Reuters.  TSMC, Samsung Lead Recovery In Asia's Emerging Markets With AI And Chip Sector Growth

Benzinga - by Neil Dennis, Benzinga Staff Writer.

Following deep losses in 2022, many emerging market assets were at bargain valuations and the recovery began in late 2022, driven by tech stocks such as Taiwan Semiconductor Manufacturing Co (NYSE:TSM) and Samsung Electronics Co (OTC:SSNLF).

Emerging market equities — particularly in the manufactured goods sectors — are deeply tied to the cyclical performance of the U.S. economy, relying on exports to the world’s biggest consumer market.

The iShares Core MSCI Emerging Markets ETF (NYSE:IEMG), an exchange traded fund that includes both TSMC and Samsung among its top holdings, hit a record-high close of $70 in February 2021 as the clamor for new tech from COVID-19 lockdown-restricted U.S. consumers drove domestic shares of both companies to all-time highs.

But, as the Federal Reserve embarked on its rate hike cycle in 2022 — that would eventually see U.S. rates hit 5.25-5.5% in mid 2023 — EM equity markets collapsed.

The IEMG ETF slumped 41% from its 2021 peak to an October 2022 trough of $41.44.

At this point, many emerging markets were seen as poisonous to investors. Growing trade tensions between the U.S. and China saw once-popular Chinese-listed stocks such as Alibaba Group Holdings (NYSE:BABA) and Tencent Holdings (OTC:TCEHY) tumble even further.

Also Read: Microsoft’s GenAI Advantage Is ‘Distancing It From The Competition,’ Says Analyst

Tech-Driven Recovery

Wedded to this was the vast growth in artificial intelligence research and development that drove the U.S.-listed Magnificent Seven stocks such as Microsoft Corporation and Nvidia Corporation to new highs through 2023.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

“All of this occurred despite the largest increase of interest rates in decades, wars in Ukraine and the Middle East, high energy prices, a regional banking crisis, and a recession in parts of the eurozone,” said analysts at Lazard Asset Management.

But, unlike in the U.S., where stock indices and the ETFs that track them, recovered to new record highs in 2023, emerging markets losses of 2022 have yet to rebound.

“We believe emerging markets remain one of the most mispriced asset classes globally,” Lazard said.

Its analysts added: “While absolute valuation levels have moved higher since they bottomed in the fourth quarter of 2022, relative to developed market equities, valuations remain generally inexpensive.

“Valuation discounts relative to developed markets and U.S. equities are hovering near 30% and 40%, respectively.”

Even as concerns mount that the valuations of some of the U.S. mega-cap stocks are becoming stretched, investors continue to gravitate towards them. Thus, if a U.S. market correction should occur in 2024, emerging market valuation discounts could present investors with alternatives.

Since its October 2024 trough, the IEMG ETF has regained 22.6% to $50.80.

Mitigating China Risk

Further news on these measures could come at this week’s National People’s Congress, China’s flagship annual political event, where the Communist party is expected to outline how it plans to deal with its geopolitical and economic challenges, including its ongoing real estate crisis.

If investors don’t like the China exposure in the IEMG ETF — which is minimal — iShares offers the MSCI Emerging Markets Ex-China ETF (NYSE:EMXC), which strips out Chinese-listed stocks, and has climbed 30% since its October 2022 low.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Now Read: Netflix’s 2024 Gains Is Cinema’s Loss: AMC Shares Slump Despite Box Office Boost From Taylor Swift, Beyoncé

Photo: Shutterstock

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.